NCT Number: NCT00893139
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Composite corneal staining score of greater than 5 in one or both eyes.
- Schirmer II score of greater than 4 mm.
- OSDI score of greater than 23.
- Other protocol-defined inclusion criteria may apply.
Exclusion criteria
- Any medical condition (systemic or ophthalmic) that may, in the opinion of the investigator, preclude the safe administration of the test article or safe participation in this study.
- Other protocol-defined exclusion criteria may apply.
Treatment and study plan
AL-38583 ophthalmic solution 0.10%
DrugAL-38583 vehicle
DrugInactive ingredients used as a placebo comparator
Primary outcomes
-
Mean change from baseline in sodium fluorescein corneal staining score
Time frame: Baseline, up to Day 35
Secondary outcomes
-
Mean change from baseline in phenol red thread length
Time frame: Baseline, up to Day 35
Sponsors and collaborators
Lead sponsor
Alcon Research
Industry
Registry information
Important dates
- Study start
- 2009
- Primary completion
- 2010
- Study completion
- 2010
- First posted
- May 5, 2009
- Registry last updated
- Jul 15, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cord Blood Platelet Poor Plasma Eye Drops
NCT07089511
Dry Eye, Dry Eye Syndromes
Milan, Italy
View Trial DetailsA Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
NCT06346340
Dry Eye, Dry Eye Syndromes
Laguna Hills, California, United States
View Trial DetailsSystemic Isotretinoin Therapy and Eye
NCT07675460
Acne Cystic, Choroidal Thickness
Kayseri, Turkey (Türkiye)
View Trial DetailsSafety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
NCT04418999
Allergy, Corneal Diseases
Chicago, Illinois, United States
View Trial Details